Masa‐Aki Ikeda

2.6k citations
68 papers · 2.1k indexed · h-index 24
Topics
Cancer-related Molecular Pathways (25 papers)RNA modifications and cancer (10 papers)Virus-based gene therapy research (6 papers)
Partner nations
JapanTürkiyeMalaysia

In The Last Decade

Masa‐Aki Ikeda

64 papers receiving 2.1k citations

Peers

Masa‐Aki Ikeda
Comparison fields: 5 of 109
  • Molecular Biology 1.4k
  • Oncology 637
  • Cell Biology 329
  • Genetics 215
  • Cancer Research 213
Replace Lizhi Lu with:
Lizhi Lu China
Yaron Fuchs Israel
Zheng Cui China
Kotaro Sugimoto Japan
Rong Zhang China
Ari Rinne Finland
Francis James Grant United States
Manuel Reina Spain
William R. Huckle United States
Masa‐Aki Ikeda relative to Lizhi Lu China Lizhi Lu's profile →
Citations per field
00.5×2.7×
Lizhi Lu · 1×
Citations per year

Countries citing papers authored by Masa‐Aki Ikeda

Since Specialization
Citations

This map shows the geographic impact of Masa‐Aki Ikeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masa‐Aki Ikeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masa‐Aki Ikeda more than expected).

Fields of papers citing papers by Masa‐Aki Ikeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masa‐Aki Ikeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masa‐Aki Ikeda. The network helps show where Masa‐Aki Ikeda may publish in the future.

Co-authorship network of co-authors of Masa‐Aki Ikeda

This figure shows the co-authorship network connecting the top 25 collaborators of Masa‐Aki Ikeda. A scholar is included among the top collaborators of Masa‐Aki Ikeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masa‐Aki Ikeda. Masa‐Aki Ikeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 6
2 6
3 11
4 8
5 12
6 17
7 19
8 12
9 91
10 30
11 56
12 34
13 61
14 102
15 10
16 112
17 31
18 2
19
IS042 G1 Cyclin-Dependent Kinase Activity is Required for the Development of Cardiomyocyte Hypertrophy
2
20 6

About Masa‐Aki Ikeda

Masa‐Aki Ikeda is a scholar working on Developmental Neuroscience, Oncology and Molecular Biology, having authored 68 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (25 papers), RNA modifications and cancer (10 papers) and Virus-based gene therapy research (6 papers). The work is most often cited by research in Oncology (637 citations), Cell Biology (329 citations) and Molecular Biology (1.4k citations). Masa‐Aki Ikeda has collaborated with scholars based in Japan, Türkiye and Malaysia. Frequent co-authors include Joseph R. Nevins, Laszlo Jakoi, Mimi Tamamori‐Adachi, Kazuhiro Eto, Piyamas Sumrejkanchanakij, Kanchanamala Withanage, Y. Hata, Yongbo Bao, Yayoi Ikeda and Fumiaki Marumo. Their work appears in journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Circulation Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026